http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2259180-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2003-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5084249f5b79c876b055988b36d29e58 |
| publicationDate | 2005-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2259180-C2 |
| titleOfInvention | Method for treating ophthalmic manifestations of diseases transmitted via sexual intercourse |
| abstract | FIELD: medicine. n SUBSTANCE: method involves administering etiotropic anti-inflammatory desensitizing and blood-vessel-strengthening preparations. 1.5% sodium deoxyribonucleate (Derinate) is additionally intramuscularly administered every other day in a course of 5 to 10 injections. The 0.25% sodium deoxyribonucleate (Derinate) is administered as single dose in to the nasal cavity and into the eye conjunctiva cavity 6 times a day. n EFFECT: enhanced effectiveness of treatment. n 1 tbl |
| priorityDate | 2003-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553 |
Total number of triples: 13.